CHIRICOZZI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 3.734
NA - Nord America 3.431
AS - Asia 3.093
SA - Sud America 341
AF - Africa 90
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.700
Nazione #
US - Stati Uniti d'America 3.331
CN - Cina 1.106
IT - Italia 1.003
SG - Singapore 944
GB - Regno Unito 827
DE - Germania 705
HK - Hong Kong 273
SE - Svezia 264
BR - Brasile 258
RU - Federazione Russa 216
IN - India 172
JP - Giappone 159
NL - Olanda 121
DK - Danimarca 116
FR - Francia 114
VN - Vietnam 97
IE - Irlanda 84
TR - Turchia 79
ID - Indonesia 74
CA - Canada 62
FI - Finlandia 55
KR - Corea 51
CI - Costa d'Avorio 45
UA - Ucraina 43
AR - Argentina 33
AT - Austria 30
BE - Belgio 29
CH - Svizzera 26
MX - Messico 25
CZ - Repubblica Ceca 17
ES - Italia 17
IQ - Iraq 17
TW - Taiwan 15
PL - Polonia 14
AE - Emirati Arabi Uniti 13
PH - Filippine 12
GR - Grecia 11
PE - Perù 11
VE - Venezuela 11
ZA - Sudafrica 11
BD - Bangladesh 10
CL - Cile 9
CO - Colombia 8
EU - Europa 8
IR - Iran 8
LT - Lituania 8
MA - Marocco 8
RO - Romania 8
IL - Israele 7
SA - Arabia Saudita 7
SC - Seychelles 7
EG - Egitto 6
NO - Norvegia 6
TH - Thailandia 6
UZ - Uzbekistan 6
AU - Australia 5
EC - Ecuador 5
HR - Croazia 5
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LK - Sri Lanka 4
PK - Pakistan 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
BW - Botswana 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
IM - Isola di Man 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
GA - Gabon 1
GE - Georgia 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 10.704
Città #
Southend 748
Milan 607
Singapore 546
Dallas 471
Ashburn 442
Hanover 334
Chandler 260
Hong Kong 248
Beijing 199
Fairfield 138
Frankfurt am Main 133
Hefei 131
Council Bluffs 121
Wilmington 119
Ann Arbor 115
Princeton 102
Dublin 84
Santa Clara 81
Seattle 75
Los Angeles 73
Dearborn 67
Houston 66
Woodbridge 61
New York 58
Bengaluru 55
Jakarta 51
Nanjing 51
Buffalo 46
Abidjan 45
Cambridge 45
Shanghai 45
Columbus 42
Menlo Park 42
The Dalles 41
Munich 40
Istanbul 38
Tokyo 37
Des Moines 35
Phoenix 35
Ponte San Pietro 34
Moscow 32
Boardman 31
Ho Chi Minh City 31
Nuremberg 31
Redwood City 30
Cangzhou 29
Guangzhou 28
Seoul 28
Jinan 24
Chigasaki 23
Ichikawa 23
Brussels 22
Hanoi 22
Toronto 22
Mountain View 21
Berlin 17
Tianjin 17
Zhengzhou 17
Bühl 16
Changsha 16
Falls Church 16
Helsinki 16
Fuzhou 15
Hangzhou 15
Jiaxing 15
Ottawa 15
Pune 15
Atlanta 14
Nanchang 14
Rio de Janeiro 14
São Paulo 14
Turku 14
Inzai 13
Limbiate 13
Shenyang 13
Vienna 13
Boston 12
Chicago 12
Kent 12
London 12
Rome 12
Brescia 11
Novara 11
Central District 10
Curitiba 10
Córdoba 10
Dong Ket 10
Hebei 10
Lima 10
Naples 10
San Diego 10
Taipei 10
Amsterdam 9
Düsseldorf 9
Qingdao 9
Stockholm 9
Chennai 8
Ningbo 8
Redmond 8
Shenzhen 8
Totale 6.910
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 575
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/- mouse model 485
Gangliosides in Membrane Organization 338
Sphingolipids and neuronal degeneration in lysosomal storage disorders 307
The Neuroprotective Role of the GM1 Oligosaccharide, II3Neu5Ac-Gg4, in Neuroblastoma Cells 306
SPHINGOLIPIDS AS SIGNALING MOLECULES: THEIR INVOLVEMENT IN HEALTH AND DISEASE. 270
Lyn-coupled LacCer-enriched lipid rafts in neutrophilis : a possible organization 264
Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection 240
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 237
GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route 232
GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkA 227
Evidence for the involvement of lipid rafts and plasma membrane sphingolipid hydrolases in pseudomonas aeruginosa infection of cystic fibrosis bronchial epithelial cells 225
GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration 223
Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide 218
Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia 211
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro 206
The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells 202
Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells 192
Novel insights on GM1 and Parkinson's disease: A critical review 190
Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells 180
GM1 neuroprotective properties are related to GM1 oligosaccharide 180
Current and novel aspects on the non-lysosomal β-Glucosylceramidase GBA2 179
Characterization of the GM1 oligosaccharide transport across the blood-brain-barrier 176
Cell surface glycohydrolase modulation during tumor irradiation 171
GM1 neurotrophic properties are related to GM1 oligosaccharide - TRKA interaction. 170
Glycosphingolipids 159
Glycosphingolipid patterns and glycohydrolases behavior in acid-sphingomyelinase knock-out mice 152
GM1 neurotrophic properties are related to gm1oligosaccharide - TrkA interaction in mouse neuroblastoma cells 152
Oligosaccaridi per l’uso nel trattamento della malattia di Parkinson 151
The Neurotrophic properties of GM1 oligosaccharide: a new promising story 150
GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP 148
Study of the neurodifferentiative role of GM1 oligosaccharide chain in mouse primary cerebellar neurons 144
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 143
On the use of cholera toxin 141
The oligosaccharide portion of ganglioside GM1 as mitochondrial regulator 137
Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cells 131
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils 129
Serum antibodies to glycans in peripheral neuropathies 129
Mitochondrial modulation: a novel role for GM1 oligosaccharide 128
Glycohydrolases and glycosphingolipids behavior in acid-sphingomyelinase knock-out mice 123
Neurotrophic properties of gm1 oligosaccharide: evidence on the development of primary neurons in culture 123
Lipid rafts and neurological diseases 120
Plasma membrane glycosphingolipid signaling: a turning point 119
Secondary alterations of sphingolipid metabolism in lysosomal storage diseases 118
GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation 115
Secondary accumulations of gangliosides in sphingolipidosis 115
Neuronal membrane dynamics as fine regulator of sphingolipid composition 115
Secondary Alterations of Sphingolipid Metabolism in Lysosomal Storage Diseases 114
GM3 synthase deficiency causes lysosomal and mitochondria impairment 113
GM1 structural requirements to mediate neuronal functions 111
Methods for Assay of Ganglioside Catabolic Enzymes 109
Effects of the scaffold proteins liprin-alpha 1, beta 1 and beta 2 on invasion by breast cancer cells 108
Turning the spotlight on the oligosaccharide chain of GM1 ganglioside 105
Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition 103
The structure of gangliosides hides a code for determining neuronal functions 102
Ionizing radiations increase the activity of the cellsurface glycohydrolases and the plasma membrane ceramide content 101
Pyrimethamine chaperone enhances betahexosaminidase activity in Sandhoff fibroblasts without restoring lysosomal GM2 catabolism 98
GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons 97
LXR-silencing induces apoptosis by glycosphingolipderived ceramide in different tumor cell type 89
Group IIA secretory phospholipase A2 (sPLA2-IIA) activation contributes to apoptosis after NMDA-receptor over-activation in primary neurons 88
Group IIA secretory phospholipase A2 (GIIA) mediates apoptotic death during NMDA receptor activation in rat primary cortical neurons 87
GM1 as adjuvant of innovative therapies for cystic fibrosis disease 86
Reduction in cholesterol supply by Mecp2 null astrocytes contributes to synaptic defects 80
Chaperone Therapy for GM2 Gangliosidosis: Effects of Pyrimethamine on β-Hexosaminidase Activity in Sandhoff Fibroblasts 79
Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions 73
Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model 72
Effect of CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor on lipid metabolism in human bronchial epithelial cells 67
GM1 oligosaccharide-mediated rescue in GBA-linked Parkinson’s disease via modulation of lysosomal and mitochondrial dysfunctions 65
Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells 14
Totale 11.107
Categoria #
all - tutte 33.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021522 0 0 0 0 0 108 32 63 76 109 46 88
2021/20221.118 92 47 39 119 94 78 65 92 173 118 85 116
2022/2023945 107 99 96 93 83 169 12 75 118 11 50 32
2023/20241.017 23 45 47 84 270 48 58 68 25 73 144 132
2024/20252.367 108 272 99 190 166 99 99 238 132 244 221 499
2025/20262.664 536 448 794 438 396 52 0 0 0 0 0 0
Totale 11.107